Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Seroma 4Melanoma 3Postoperative Complications 2Breast Neoplasms 2Vulvar Neoplasms 1Stomach Neoplasms 1Lymphoma, Follicular 1Lymphocele 1Lymphedema 1Hemorrhage 1Carcinoma, Squamous Cell 1Bone Neoplasms 1Anastomotic Leak 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Fibrin Tissue Adhesive × Clear all
NCT01649505 2022-11-02

Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast Reconstruction

OHSU Knight Cancer Institute

Phase NA Terminated
2 enrolled 5 charts
Breast

Breast Neoplasms, Postoperative Complications

NCT00909649 2009-05-28

MRM

Mansoura University

Phase NA Completed
50 enrolled 6 charts
Breast

Breast Neoplasms, Seroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡